No Mortality Benefit from CABG When Added to Optimal Medical Therapy in Patients with CAD and LV Dysfunction: Results from the STICH Trial

Article Information

DOI 
http://dx.doi.org/10.1177/155989771103012
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2011 MD Conference Express

Author Information

  1. Eric J. Velazquez, MD
    1. Duke University, Durham, North Carolina, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
May 2015100
Aug 2015200
Sep 2015100
Oct 2015343
Total1343

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
No Mortality Benefit from CABG When Added to Optimal Medical Therapy in Patients with CAD and LV Dysfunction: Results from the STICH Trial
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Heart Failure
Interventional Techniques & Devices Clinical Trials